Home » Topics » Regulatory

Regulatory
RSS

New formulation of enalapril now available in U.K.

Feb. 4, 1998

Zeneca receives patent protection for new Diprivan formulation

Feb. 4, 1998

NexMed completes phase I trial of ED product

Feb. 4, 1998

Crescendo and Alza to collaborate on chronic pain product

Feb. 3, 1998

Topical interferon alfa enters phase II for intravaginal warts

Feb. 2, 1998

Controlled-release oxybutynin to be marketed in Europe by Synthelabo

Feb. 2, 1998

Suramin submitted for FDA approval for cancer indication

Jan. 30, 1998

Proleukin cleared for marketing in U.S. for melanoma indication

Jan. 30, 1998

Anesta signs European marketing agreement for Actiq

Jan. 29, 1998

New once-daily rosacea therapy introduced in U.S.

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...